Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 146,954 |
|
|||||
| News | - | ||||||
| Day High | 5.38 | Low High |
|||||
| Day Low | 5.04 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Delcath Systems Inc | DCTH | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.20 | -3.67% | 5.25 | 15:02:45 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 5.38 | 5.04 | 5.38 | 5.25 | 5.45 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,413 | 146,954 | US$ 5.26 | US$ 772,595 | - | 2.25 - 7.99 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:04 | 3,838 | US$ 5.26 | USD |
Delcath Systems Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 115.96M | 22.05M | - | 2.07M | -47.68M | -2.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Delcath Systems News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DCTH Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.43 | 5.7415 | 4.26 | 5.22 | 315,760 | 0.82 | 18.51% |
| 1 Month | 5.03 | 5.7415 | 4.26 | 4.99 | 247,148 | 0.22 | 4.37% |
| 3 Months | 4.85 | 5.7415 | 3.70 | 4.62 | 209,191 | 0.40 | 8.25% |
| 6 Months | 3.55 | 5.7415 | 2.25 | 3.78 | 293,363 | 1.70 | 47.89% |
| 1 Year | 5.90 | 7.99 | 2.25 | 5.10 | 735,200 | -0.65 | -11.02% |
| 3 Years | 11.46 | 14.95 | 2.25 | 5.34 | 274,270 | -6.21 | -54.19% |
| 5 Years | 3.77 | 25.18 | 2.25 | 6.48 | 237,297 | 1.48 | 39.26% |
Delcath Systems Description
| Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. |
